Prolonged hepatic cholestasis after flucloxacillin therapy
- 1 December 1989
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 151 (11-12), 701-705
- https://doi.org/10.5694/j.1326-5377.1989.tb139652.x
Abstract
A severe prolonged illness that was characterized by deep jaundice and debilitating pruritus occurred in five patients after the use of flucloxacillin. The symptoms and signs of liver disease took at least two months to resolve; after four- to nine-months'' follow-up, liver enzyme activities have remained abnormal in all patients. Examination of liver biopsy specimens showed severe cholestasis in all cases, with evidence of significant bile-duct injury in three cases. In one patient, in whom symptoms have persisted for nine months, examination of a liver biopsy specimen showed marked bile-duct depletion. All patients were seen during a four-month period and it is felt that flucloxacillin-induced liver disease probably has been underdiagnosed and underreported. The use of flucloxacillin has been increasing rapidly and it is anticipated that more cases of flucloxacillin hepatotoxicity will occur in the future.This publication has 11 references indexed in Scilit:
- Treatment of pruritus in primary biliary cirrhosis with rifampinGastroenterology, 1988
- Co-trimoxazole-induced hepatic injury — an analysis of cases with hypersensitivity-like reactionsInfection, 1987
- Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitizationArchives of Internal Medicine, 1987
- Enflurane-induced hepatitis with prominent cholestasisCleveland Clinic Journal of Medicine, 1987
- Prolonged Severe Cholestasis Induced by Oxacillin DerivativesActa Medica Scandinavica, 1985
- Enflurane HepatotoxicityAnnals of Internal Medicine, 1983
- Haloperidol-Induced Chronic Cholestatic Liver DiseaseGastroenterology, 1982
- Severe penicillin-induced cholestasis in a 91-year-old womanDigestive Diseases and Sciences, 1981
- Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs.BMJ, 1980
- Cholestatic Hepatitis Following the Administration of Sodium OxacillinJAMA, 1965